Savita Bhargav

Dr. Savita Bhargav


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2018 in Reproductive Health
Verified
Journal Article
Open access
PDF file
FGfor the Pregnancy and Influenza Multinational Epidemiologic (PRIME) Study Working Group*
for the Pregnancy and Influenza Multinational Epidemiologic (PRIME) Study Working Group*
FDFatimah S. Dawood
Fatimah S. Dawood
DHDanielle Hunt
Danielle Hunt
APArchana Patel
Archana Patel
WKWanitchaya Kittikraisak
Wanitchaya Kittikraisak
EAEduardo Azziz-Baumgartner
Eduardo Azziz-Baumgartner
The World Health Organization identifies pregnant women as at high-risk for severe influenza, but influenza vaccines are underutilized among pregnant women. Data on influenza burden during pregnancy are largely limited to high-income countries and data on the impact of influenza on birth and perinatal outcomes are scarce. This prospective, longitudinal cohort study of pregnant women in middle-income countries is designed to address three primary objectives: 1) to evaluate the effect of laboratory-confirmed influenza during pregnancy on pregnancy and perinatal outcomes; 2) to estimate the incidences of all-cause acute respiratory illness and laboratory-confirmed influenza during pregnancy; and 3) to examine the clinical spectrum of illness associated with influenza viruses. Through a multi-country network approach, three sites aim to enroll cohorts of 1500–3000 pregnant women just before local influenza seasons. Women aged ≥ 18 years with expected delivery dates ≥ 8 weeks after the start of the influenza season are eligible. Women are followed throughout pregnancy through twice weekly surveillance for influenza symptoms (≥ 1 of myalgia, cough, runny nose, sore throat, or difficulty breathing) and have mid-turbinate nasal swabs collected for influenza virus testing during illness episodes. Primary outcomes include relative risk of preterm birth and mean birth weight among term singleton infants of women with and without reverse transcription polymerase chain reaction-confirmed influenza during pregnancy. Gestational age is determined by ultrasound at < 28 weeks gestation and birth weight is measured by digital scales using standardized methods. Sites are primarily urban in Bangkok, Thailand; Lima, Peru; and Nagpur, India. All sites recruit from antenatal clinics at referral hospitals and conduct surveillance using telephone calls, messaging applications, or home visits. Nasal swabs are self-collected by participants in Thailand and by study staff in Peru and India. During the first year (2017), sites enrolled participants during March–May in Peru and May–July in India and Thailand; 4779 women were enrolled. This study aims to generate evidence of the impact of influenza during pregnancy to inform decisions by Ministries of Health, healthcare providers, and pregnant women in middle-income countries about the value of influenza vaccination during pregnancy.

4 September 2019 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
APArchana Patel
Archana Patel
ABAkash Bang
Akash Bang
KKKunal Kurhe
Kunal Kurhe
SBSavita Bhargav
Savita Bhargav
APAmber Prakash
Amber Prakash
PHPatricia L. Hibberd
Patricia L. Hibberd
The Helping Babies Breathe (HBB) educational program focuses on training of first-level birth attendants in neonatal resuscitation skills for the first minute of life (The Golden Minute). Pre-post studies of HBB implementation in sub-Saharan Africa and Asia have shown reductions in facility-based very early neonatal mortality and stillbirth rates. However, the Global Network pre-post HBB Implementation Study (GN-HBB-IS) found no difference in day 7 perinatal mortality rates (PMR-D7) among births to women participating in the Global Network’s Maternal and Newborn Health Registry. To address potential differences in perinatal outcomes in births occurring in facilities that implemented HBB vs. all births occurring in the communities served by facilities that implemented HBB, we compared day-1 perinatal mortality rates (PMR-D1) among births occurring pre and post HBB implementation in facilities in Nagpur, India, one of the 3 sites participating in the GN-HBB-IS. We hypothesized that there would be a 20% decrease in the Nagpur facility based PMR-D1 in the 12 months post GN HBB implementation from the pre-period. We explored pre-post differences in stillbirth rates (SBR) and day-1 neonatal mortality rates (NMR-D1). Of the 15 facilities trained for the GN-HBB-IS, 13 participated in the Nagpur HBB Facility Study (Nagpur-HBB-FS). There were 38,078 facility births in the 12 months before the GN-HBB-IS and 40,870 facility births in the 12 months after the GN-HBB-IS. There was 11% overlap between the registry births analyzed in the GN-HBB-IS and the facility births analyzed in the Nagpur-HBB-FS. In the Nagpur-HBB-FS, there was a pre-post reduction of 16% in PMR-D1 (p = 0.0001), a 14% reduction in SBR (p = 0.002) and a 20% reduction NMR-D1 (p = 0.006). In the Nagpur-HBB-FS, PMR-D1, stillbirths and NMR-D1 were significantly lower after HBB implementation. These benefits did not translate to improvements in PMR-D7 in communities served by these facilities, possibly because facilities in which HBB was implemented covered an insufficient proportion of community births or because additional interventions are needed after day 1 of life. Further studies are needed to determine how to translate facility-based improvements in PMR-D1 to improved neonatal survival in the community. The Global Network HBB Implementation Study (GN-HBB-IS) was registered at ClinicalTrials.gov: NCT01681017 .

10 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MMManju Mamtani
Manju Mamtani
KKKunal Kurhe
Kunal Kurhe
APAshwini Patel
Ashwini Patel
MJManisha Jaisinghani
Manisha Jaisinghani
KPKanchan V. Pipal
Kanchan V. Pipal
HKHemant Kulkarni
Hemant Kulkarni
Background: The definitions and approaches used to diagnose gestational diabetes (GD) are varied. The two-step approach recommended by the American College of Obstetricians and Gynecologists (ACOG) combines the sensitivity of a glucose challenge test (GCT) with the specificity of a 3-hour oral glucose tolerance test (OGTT). We investigated if minor modification of the two-step procedure can provide improved detection of GD by identifying a risk group of pregnant women with high risk of GD. Methods: We conducted a prospective cohort study of pregnant women enrolled early during pregnancy and followed till delivery. All participants underwent the ACOG-recommended two-step procedure for GD diagnosis. Based on GCT and OGTT results, the participants were divided into four risk groups (RGs): GCT-negative (RG0), GCT-positive but OGTT normal (RG1), single abnormal value on OGTT or raised HbA1c (RG2) and diagnosed GD (RG3). Baseline evaluation included dietary history (24 hour recall) and physical activity. A series of multivariable logistic regression analyses were conducted to estimate the odds of maternal and fetal outcomes. Results: A total of 1041 pregnant women were included in the study, of whom 16 (1.6%) were diagnosed as GD. Our two-step approach identified 48 (4.6%) women as GD, while RG2, RG1 and RG0 comprised 75 (7.2%), 218 (20.9%) and 700 (67.2%), respectively. Compared to RG0, RG2 showed a higher likelihood of antepartum complications [odds ratio and 95% confidence interval 2.38 (1.16–4.15)], any adverse outcome without [2.04 (1.17–3.55)] or with cesarean section [2.09 (1.21–3.61)] and primary cesarean section [1.68 (1.01–2.81)] after adjustment for potential confounders. RG2 was also significantly associated with pregnancy-induced hypertension, meconium-stained amniotic fluid and premature rupture of membranes. Conclusions: In the study participants, we identified a subgroup (RG2) at high risk of GD with perinatal outcomes showing profile consistent with that of GD.

26 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
HKHemant Kulkarni
Hemant Kulkarni
MMManju Mamtani
Manju Mamtani
KKKunal Kurhe
Kunal Kurhe
APAshwini Patel
Ashwini Patel
MJManisha Jaisinghani
Manisha Jaisinghani
APArchana Patel
Archana Patel
Background: Current guidelines by the American College of Obstetrics and Gynecology require a two-step procedure for diagnosis of gestational diabetes (GD). This two-step procedure is challenging in resource limited settings. We determined if electrocardiography (ECG) done combined with artificial intelligence techniques can predict GD to provide a non-invasive, early gatekeeper strategy for GD risk stratification. Methods: Data for this study came from the Markers of Early Risk-stratification of Gestational Diabetes (MERGD) study and included 10s, 12-lead ECGs collected at the first antenatal visit. Patients were invited to undergo GCT at 24-28 weeks and, if required, an OGTT was conducted. GCT result was considered positive if the 1-hour, 50g glucose load blood glucose level was ≥130 mg/dL. ECGs were preprocessed, filtered, and a synthetic dataset was generated by using features from autoencoders, device-reported variables and heart rate variability parameters. A random forest model (RF-ECG) was trained on the synthetic data and validated first by 10-fold cross-validation, then on a held-out test of the synthetic data and finally on the original data not seen by the model. Results: Total 1,036 quality checked, preprocessed ECGs were used in the study. A total of 123 (11.87%) women developed GD. The fully trained RF-ECG model provided validation performance as follows: 78.28% accuracy, 87.80% sensitivity, 77.00% specificity and a likelihood ratio of positive test of 3.82. The RF-ECG model outperformed existing models of GD risk stratification. Importance metric identified 40 features as contributory to the model’s diagnostic logic. Conclusions: ECGs can accurately predict the likelihood of GD ahead of the final diagnosis. If supported by external validation in future studies, our approach can help noninvasively identify GD risk early during pregnancy in resource limited settings.

26 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MMManju Mamtani
Manju Mamtani
KKKunal Kurhe
Kunal Kurhe
APAshwini Patel
Ashwini Patel
MJManisha Jaisinghani
Manisha Jaisinghani
KPKanchan V Pipal
Kanchan V Pipal
HKHemant Kulkarni
Hemant Kulkarni
Background: The definitions and approaches used to diagnose gestational diabetes (GD) are varied. The two-step approach recommended by the American College of Obstetricians and Gynecologists (ACOG) combines the sensitivity of a glucose challenge test (GCT) with the specificity of a 3-hour oral glucose tolerance test (OGTT). We investigated if minor modification of the two-step procedure can provide improved detection of GD by identifying a risk group of pregnant women with high risk of GD. Methods: We conducted a prospective cohort study of pregnant women enrolled early during pregnancy and followed till delivery. All participants underwent the ACOG-recommended two-step procedure for GD diagnosis. Based on GCT and OGTT results, the participants were divided into four risk groups (RG)s: GCT negative (RG0), GCT positive but OGTT normal (RG1), single abnormal value on OGTT or raised HbA1c (RG2) and diagnosed GD (RG3). Baseline evaluation included dietary history (24-hour recall) and physical activity. A series of multivariable logistic regression analyses were conducted to estimate the odds of maternal and fetal outcomes. Results: A total of 1,041 pregnant women were included in the study of who 16 (1.6%) were diagnosed as GD. Our two-step approach identified 48 (4.6%) women as GD while the RG2, RG1 and RG0 groups comprised 75 (7.2%), 218 (20.9%) and 700 (67.2%), respectively. Compared to RG0, the RG2 group showed a higher likelihood of antepartum complications [odds ratio and 95% confidence interval 2.38 (1.16-4.15)], any adverse outcome without [2.04 (1.17-3.55)] or with cesarean section [2.09 (1.21-3.61)], and primary cesarean section [1.68 (1.01-2.81)] after adjustment for potential confounders. The RG2 group was also significantly associated with pregnancy induced hypertension, meconium-stained amniotic fluid and premature rupture of membranes. Conclusions: In the study participants, we identified a subgroup (RG2) at high risk of GD with perinatal outcomes showing profile consistent with that of GD.